Search by Drug Name or NDC

    NDC 50383-0771-16 Docu Liquid 50 mg/5mL Details

    Docu Liquid 50 mg/5mL

    Docu Liquid is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Akorn Operating Company LLC. The primary component is DOCUSATE SODIUM.

    Product Information

    NDC 50383-0771
    Product ID 50383-771_5ac421b1-7808-4afb-8e1c-706b77b0e090
    Associated GPIs 46500010300910
    GCN Sequence Number 003017
    GCN Sequence Number Description docusate sodium LIQUID 50 MG/5 ML ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 09131
    HICL Sequence Number 001326
    HICL Sequence Number Description DOCUSATE SODIUM
    Brand/Generic Generic
    Proprietary Name Docu Liquid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Docusate Sodium
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/5mL
    Substance Name DOCUSATE SODIUM
    Labeler Name Akorn Operating Company LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2023-12-31

    Package

    NDC 50383-0771-16 (50383077116)

    NDC Package Code 50383-771-16
    Billing NDC 50383077116
    Package 473 mL in 1 BOTTLE (50383-771-16)
    Marketing Start Date 1997-08-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01191
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description DOCU LIQUID 50 MG/5 ML
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 7fdc4368-4888-4792-86d3-c8a828e4fff2 Details

    Revised: 10/2022